Drug Type Small molecule drug |
Synonyms 3,4,5-tri-O-galloylquinic acid methyl ester |
Target |
Mechanism ANXA1 antagonists(annexin A1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H26O18 |
InChIKeyAMPWJGZELUTIOV-KSJUVHMPSA-N |
CAS Registry125369-71-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Calculi | Preclinical | BR | 13 Feb 2018 |